Results 191 to 200 of about 140,832 (267)

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

open access: yesAlimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 383-395, February 2026.
In a cohort of 1596 liver cancer patients with either current or prior HBV infection undergoing systemic therapy in Hong Kong, the risk of HBV reactivation during immune checkpoint inhibitor treatment was low when adequate antiviral prophylaxis was administered, irrespective of HBV infection status.
Dorothy Cheuk‐Yan Yiu   +9 more
wiley   +1 more source

Incidental Detection of Microfilariae in Saguinus bicolor and Saguinus midas From Central Amazon

open access: yesJournal of Medical Primatology, Volume 55, Issue 1, February 2026.
ABSTRACT Callitrichid primates Saguinus bicolor and Saguinus midas from urban accidents in peri‐urban forests from Central Amazon were necropsied. Analysis of thoracic and peritoneal fluid showed that 56.5% (13/23) of S. bicolor individuals and 13.3% (4/30) of S.
Christiano T. Figueiredo   +4 more
wiley   +1 more source

Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta‐Analysis

open access: yesLiver International, Volume 46, Issue 2, February 2026.
ABSTRACT Background & Aims Metabolic associated steatotic liver disease (MASLD) is increasing in prevalence worldwide. Clinical practice is focused on identifying those with cirrhosis and monitoring for complications such as varices and hepatocellular carcinoma (HCC).
Rachael Barrett   +5 more
wiley   +1 more source

Should Elective TIPS be Placed in Non‐Abstinent Patients With Alcohol‐Related Cirrhosis?

open access: yes
United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
Marika Rudler, Dominique Thabut
wiley   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

open access: yesAdvanced Functional Materials, Volume 36, Issue 1, 2 January 2026.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth   +2 more
wiley   +1 more source

Risk factors of peritoneal dialysis–related peritonitis in the Japan Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) [PDF]

open access: gold
Yasuhiko Ito   +19 more
openalex   +1 more source

Home - About - Disclaimer - Privacy